Waiver or Reduction of Medicare and Commercial Co-Payments: What DME Providers Can and Can’t Do
Thursday, April 20, 2017, 1:00 pm CT/ 2:00 pm ET
When every dollar counts in the DME industry, it is vital that suppliers make every effort to collect copayments and deductibles. In many cases, it is challenging when patients do not have supplemental insurance, and the supplier gets in the habit of routinely waiving co-payments. This is why DME suppliers need to understand that this behavior can result in an investigation from the OIG for potential fraud.
Join Jeffrey S. Baird, Esq., Chairman of the Health Care Group of Brown & Fortunato, P.C., to learn the latest DME requirements regarding co-payments from Medicare beneficiaries and commercial patients, and the steps that the supplier should take before waiving a co-payment.
This presentation will help attendees:
- Learn why the collection of copayments and deductibles is critical to the success of a business
- Analyze when it is legally acceptable to waive copayments and deductibles
- Understand what the OIG considers to be a kickback, inducement, or false claim